Company News
Taking Hold of Pharmacy’s Future
RxBenefits, Inc. Appoints Robert Gamble Chief Executive Officer
How To Break Through the Barriers Facing Biosimilars
The Cost Conundrum of GLP-1s and Their Impact on Pharmacy Spend
Pharmacy Times Part 2: What Went Wrong – How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
Chief Pharmacy Officer, Mark Campbell Featured in Pharmacy Times
Meet Our Experts: Annette Sanjines and Norm Puente
Mark Campbell Featured in BenefitsPro Article: Managing the Financial Side Effects of Specialty Drugs
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
